COMP <GO>
ALMS vs ANRO // NET PROFIT MARGIN
Alumis Inc. (NASDAQ) VS. Alto Neuroscience Inc. (NYSE) • 15-METRIC TALLY: ALMS 0
— ANRO 3
■ METRIC PARITY
LAST: $6.73 (-2.32%) • MKT CAP: $871.1M
net-margins
-60.00%
LAST: $22.60 (-3.71%) • MKT CAP: $886.9M
net-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALMS VS. ANRO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALMS | ANRO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -5.62% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | ANRO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.2 | 41.1 | -2.90 | ANRO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $871.1M | $886.9M | -$15.8M | ANRO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALMS REV | ANRO REV | ALMS GROSS % | ANRO GROSS % | ALMS FCF | ANRO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $24.1M | $0 | — | — | -$370.2M | -$51.8M |
| FY 2024 | $0 | $0 | — | — | -$256.8M | -$49.5M |
| FY 2023 | $0 | $0 | — | — | -$130.0M | -$33.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALMS // BETA —
ANRO // BETA —